First AI-Designed Vaccine Enters Human Trials: A New Era for Pandemic Defense
AI-designed vaccines could transform pandemic preparedness by moving from reactive to proactive defense. A University of Cambridge-led trial of the pEVAC-PS vaccine demonstrated that an AI-generated “super-antigen” is safe in humans. While immune responses remain modest, the technology aims to target entire families of viruses before they spill over into the population. How does AI-driven … Read more